Maravai LifeSciences Holdings Inc
NASDAQ:MRVI

Watchlist Manager
Maravai LifeSciences Holdings Inc Logo
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Watchlist
Price: 5.13 USD -4.47% Market Closed
Market Cap: 1.3B USD
Have any thoughts about
Maravai LifeSciences Holdings Inc?
Write Note

Intrinsic Value

The intrinsic value of one MRVI stock under the Base Case scenario is 2.89 USD. Compared to the current market price of 5.13 USD, Maravai LifeSciences Holdings Inc is Overvalued by 44%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MRVI Intrinsic Value
2.89 USD
Overvaluation 44%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Maravai LifeSciences Holdings Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for MRVI cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about MRVI?
Bearish
Neutral
Bullish

Fundamental Analysis

5.13 USD
-4.47%
-4.47%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Maravai LifeSciences Holdings Inc
US
Life Sciences Tools & Services
Market Cap
1.3B USD
IPO
Nov 20, 2020
Employees
470
United States of America
Market Cap
1.3B USD
Industry
Life Sciences Tools & Services
IPO
Nov 20, 2020
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Maravai LifeSciences Holdings Inc

Provide an overview of the primary business activities
of Maravai LifeSciences Holdings Inc.

What unique competitive advantages
does Maravai LifeSciences Holdings Inc hold over its rivals?

What risks and challenges
does Maravai LifeSciences Holdings Inc face in the near future?

Has there been any significant insider trading activity
in Maravai LifeSciences Holdings Inc recently?

Summarize the latest earnings call
of Maravai LifeSciences Holdings Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Maravai LifeSciences Holdings Inc.

Provide P/S
for Maravai LifeSciences Holdings Inc.

Provide P/E
for Maravai LifeSciences Holdings Inc.

Provide P/OCF
for Maravai LifeSciences Holdings Inc.

Provide P/FCFE
for Maravai LifeSciences Holdings Inc.

Provide P/B
for Maravai LifeSciences Holdings Inc.

Provide EV/S
for Maravai LifeSciences Holdings Inc.

Provide EV/GP
for Maravai LifeSciences Holdings Inc.

Provide EV/EBITDA
for Maravai LifeSciences Holdings Inc.

Provide EV/EBIT
for Maravai LifeSciences Holdings Inc.

Provide EV/OCF
for Maravai LifeSciences Holdings Inc.

Provide EV/FCFF
for Maravai LifeSciences Holdings Inc.

Provide EV/IC
for Maravai LifeSciences Holdings Inc.

Show me price targets
for Maravai LifeSciences Holdings Inc made by professional analysts.

What are the Revenue projections
for Maravai LifeSciences Holdings Inc?

How accurate were the past Revenue estimates
for Maravai LifeSciences Holdings Inc?

What are the Net Income projections
for Maravai LifeSciences Holdings Inc?

How accurate were the past Net Income estimates
for Maravai LifeSciences Holdings Inc?

What are the EPS projections
for Maravai LifeSciences Holdings Inc?

How accurate were the past EPS estimates
for Maravai LifeSciences Holdings Inc?

What are the EBIT projections
for Maravai LifeSciences Holdings Inc?

How accurate were the past EBIT estimates
for Maravai LifeSciences Holdings Inc?

Compare the revenue forecasts
for Maravai LifeSciences Holdings Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Maravai LifeSciences Holdings Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Maravai LifeSciences Holdings Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Maravai LifeSciences Holdings Inc compared to its peers.

Compare the P/E ratios
of Maravai LifeSciences Holdings Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Maravai LifeSciences Holdings Inc with its peers.

Analyze the financial leverage
of Maravai LifeSciences Holdings Inc compared to its main competitors.

Show all profitability ratios
for Maravai LifeSciences Holdings Inc.

Provide ROE
for Maravai LifeSciences Holdings Inc.

Provide ROA
for Maravai LifeSciences Holdings Inc.

Provide ROIC
for Maravai LifeSciences Holdings Inc.

Provide ROCE
for Maravai LifeSciences Holdings Inc.

Provide Gross Margin
for Maravai LifeSciences Holdings Inc.

Provide Operating Margin
for Maravai LifeSciences Holdings Inc.

Provide Net Margin
for Maravai LifeSciences Holdings Inc.

Provide FCF Margin
for Maravai LifeSciences Holdings Inc.

Show all solvency ratios
for Maravai LifeSciences Holdings Inc.

Provide D/E Ratio
for Maravai LifeSciences Holdings Inc.

Provide D/A Ratio
for Maravai LifeSciences Holdings Inc.

Provide Interest Coverage Ratio
for Maravai LifeSciences Holdings Inc.

Provide Altman Z-Score Ratio
for Maravai LifeSciences Holdings Inc.

Provide Quick Ratio
for Maravai LifeSciences Holdings Inc.

Provide Current Ratio
for Maravai LifeSciences Holdings Inc.

Provide Cash Ratio
for Maravai LifeSciences Holdings Inc.

What is the historical Revenue growth
over the last 5 years for Maravai LifeSciences Holdings Inc?

What is the historical Net Income growth
over the last 5 years for Maravai LifeSciences Holdings Inc?

What is the current Free Cash Flow
of Maravai LifeSciences Holdings Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Maravai LifeSciences Holdings Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Maravai LifeSciences Holdings Inc

Current Assets 679.1m
Cash & Short-Term Investments 578.2m
Receivables 28.9m
Other Current Assets 72.1m
Non-Current Assets 599.1m
PP&E 164.6m
Intangibles 373.6m
Other Non-Current Assets 60.9m
Current Liabilities 63.2m
Accounts Payable 9.5m
Accrued Liabilities 36.4m
Other Current Liabilities 17.4m
Non-Current Liabilities 869.8m
Long-Term Debt 547.6m
Other Non-Current Liabilities 322.2m
Efficiency

Earnings Waterfall
Maravai LifeSciences Holdings Inc

Revenue
276.9m USD
Cost of Revenue
-148.5m USD
Gross Profit
128.4m USD
Operating Expenses
-173.5m USD
Operating Income
-45.2m USD
Other Expenses
-179.5m USD
Net Income
-224.7m USD

Free Cash Flow Analysis
Maravai LifeSciences Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MRVI Profitability Score
Profitability Due Diligence

Maravai LifeSciences Holdings Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Negative Free Cash Flow
Positive Gross Profit
Exceptional 3-Year Average ROE
Negative Operating Income
51/100
Profitability
Score

Maravai LifeSciences Holdings Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

MRVI Solvency Score
Solvency Due Diligence

Maravai LifeSciences Holdings Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Average D/E
43/100
Solvency
Score

Maravai LifeSciences Holdings Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MRVI Price Targets Summary
Maravai LifeSciences Holdings Inc

Wall Street analysts forecast MRVI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRVI is 9.25 USD with a low forecast of 4.29 USD and a high forecast of 13.86 USD.

Lowest
Price Target
4.29 USD
16% Downside
Average
Price Target
9.25 USD
80% Upside
Highest
Price Target
13.86 USD
170% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MRVI?

Click here to dive deeper.

Dividends

Maravai LifeSciences Holdings Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MRVI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MRVI Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

MRVI News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one MRVI stock?

The intrinsic value of one MRVI stock under the Base Case scenario is 2.89 USD.

Is MRVI stock undervalued or overvalued?

Compared to the current market price of 5.13 USD, Maravai LifeSciences Holdings Inc is Overvalued by 44%.

Back to Top